Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

IMD Companies Inc. (OTC:ICBU) Stock Gains Momentum: Now What?

This morning hundreds of companies are going to be on the radars of investors for one reason or another, and it is quite likely that IMD Companies Inc. (OTC:ICBU) is going to be one of them. On Thursday, the company had been in the news cycle after it announced that it had concluded the acquisition of Riize LLC.

The news about an acquisition always creates a buzz among investors, and it would be interesting to see how the IMD Company stock reacts to it over the coming trading days. In the news release, the company revealed that Riize was a major emerging player in the fast-growing telemedicine industry and would soon be working on its expansion into a range of markets and products. As a consequence, there would be considerable growth and value that would accrue to IMD companies.

In this context, it should be noted that Riize had been successful in becoming an innovative online provider of personal healthcare needs of both men and women fairly quickly. In a period spanning fewer than 12 months from September 2023 through to March 2024, Riize managed to record sales growth of 6 times in terms of order volume and 3 times with regards to its online subscriber base for the product lines it offers.

Additionally, it is also working on adding products for hair growth, TRT (testosterone replacement therapy), and HRT (hormone replacement therapy) at some point in the middle of this month. The products in question would be meant for the personal care market, in which the projections for growth had been pegged at more than 8%. Other than that, Riize would also launch its telemedicine offering in Canada and would provide its medical practitioner and pharmaceutical solutions to the dynamic market. It may be a good time to add the IMD Companies stock to your watch lists.

Published by Jon Williams

Jon graduated from the University of Michigan with a degree in finance. He is an avid investor and enjoys reporting on the markets. When he is not in front of a computer he enjoys playing golf and watching basketball.